Document:

EXHIBIT
10.2

 

THIS
WARRANT AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION
IS NOT REQUIRED UNDER SUCH ACT.

 

Warrant
Shares:____________________________________________________________Date:_______, 2016

 

OXYGEN
THERAPY, INC.

 

STOCK
WARRANT

 

This
Warrant (the “Warrant”) certifies that, for value received, ________(the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the
five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe
for and purchase from Oxygen Therapy, Inc., a Delaware corporation (the “Company”), up to ______ (the
“Warrant Shares”) of the Common Stock of the Company, par value $.001 per share (“Common
Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price,
as defined in Section 2(b). This is the Warrant described in the Subscription Agreement between the Company and Holder dated as
of the date of this Warrant (the “Purchase Agreement”) and is issued to the Holder at the same time
as the issuance to the Holder of shares of Common Stock (the “Shares”).

 

1. 
Purchase of Warrant Shares.

 

(a) Number
of Shares. Subject to the terms and conditions set forth herein and in the Purchase Agreement, the Holder is entitled, upon
surrender of this Warrant at the principal office of the Company (or at such other place as the Company shall notify the Holder
in writing), to purchase the Warrant Shares.

 

(b) Exercise
Price. The purchase price for the Warrant Shares issuable pursuant to this Section 1 shall be $1.20 per share (the “Strike
Price”); provided, however, that this Warrant is callable by the Company for redemption at any time after the price
per share of Common Stock, as shown by the closing price of such Common Stock on any generally recognized securities exchange
exceeds the Strike Price by 15% or more for 10 consecutive trading days, at a price per share of $.01. The number of Warrant Shares
subject to this Warrant and the Strike Price of such Warrant Shares shall be subject to adjustment pursuant to Section 6 hereof.
Such purchase price, as adjusted from time to time, is herein referred to as the “Exercise Price.”

 

    	 		 

    	 		 

    

 

2. Exercise
Period. This Warrant shall be exercisable, in whole or in part, at any time during the period (a) commencing on the date
of this Warrant and (b) ending at 5:00 p.m. (Eastern Time) on the fifth anniversary of the date of this Warrant (the “Exercise
Period”).

 

3. Method
of Exercise.

 

(a) While
this Warrant remains outstanding and exercisable in accordance with Section 2 above, the Holder may exercise, in whole or in part,
the purchase rights evidenced hereby. Such exercise shall be effected by:

 

(i) the
surrender of the Warrant, together with a duly executed copy of the Notice of Exercise attached hereto, to the Secretary of the
Company at its principal office (or at such other place as the Company shall notify the Holder in writing); and

 

(ii) the
payment to the Company of an amount equal to the aggregate Exercise Price for the number of Warrant Shares being purchased.

 

(b) Each
exercise of this Warrant shall be deemed to have been effected immediately prior to the close of business on the day on which
this Warrant is surrendered to the Company as provided in Section 3(a) above. At such time, the person or persons in whose name
or names any certificate for the Warrant Shares shall be issuable upon such exercise as provided in Section 3(c) below shall be
deemed to have become the holder or holders of record of the Warrant Shares represented by such certificate.

 

(c) s
soon as practicable after the exercise of this Warrant in whole or in part, and in any event within twenty (20) days thereafter,
the Company at its expense will cause to be issued in the name of, and delivered to, the Holder, or as such Holder (upon payment
by such Holder of any applicable transfer taxes) may direct:

 

(i) a
certificate or certificates for the number of Warrant Shares to which such Holder shall be entitled, and

 

(ii) in
case such exercise is in part only, a new warrant or warrants (dated the date hereof) of like tenor, calling in the aggregate
on the face or faces thereof for the number of Warrant Shares equal to the number of such Warrant Shares called for on the face
of this Warrant minus the number of Warrant Shares purchased by the Holder upon all exercises made in accordance with Section
3(a) above or Section 4 below.

 

(d) Notwithstanding
the provisions of Section 2, if the Holder has not exercised this Warrant prior to the Closing of a Qualified Liquidation Event
or an Initial Public Offering, this Warrant shall automatically be deemed to be exercised in full in the manner set forth in Section
4, without any further action on behalf of the Holder, immediately prior to such closing. For purposes of this Warrant, a “Qualified
Liquidation Event” means an acquisition of the Company by merger, consolidation, stock purchase, purchase of substantially
all of the assets of the Company or otherwise, resulting in a distribution to shareholders of an amount not less than $4.00 per
share; and an “Initial Public Offering” means the closing of an underwritten public offering of the
Company’s capital stock generating gross proceeds of $25,000,000 or more. 

 

    	 	2	 

    	 		 

    

 

4. Net
Exercise. In lieu of exercising this Warrant for cash, the Holder may elect to receive shares equal to the value of this
Warrant (or the portion thereof being exercised) by surrender of this Warrant at the principal office of the Company together
with notice of such election (a “Net Exercise”). A Holder who elects a Net Exercise shall have the rights described
in Sections 3(b) and 3(c) hereof, and the Company shall issue to such Holder a number of Conversion Shares computed using the
following formula:

 

X
= Y (A – B)

A

 

Where:

 

	 	X =	The
                                         number of Warrant Shares to be issued to the Holder.
	 	 	 
	 	Y =	The
                                         number of Warrant Shares purchasable under this Warrant or, if only a portion of the
                                         Warrant is being exercised, the portion of the Warrant being cancelled (at the date of
                                         such calculation).
	 	 	 
	 	A =	The
                                         fair market value of one (1) Warrant Share (at the date of such calculation).
	 	 	 
	 	B =	The
                                         Exercise Price (as adjusted to the date of such calculations).

 

5. Covenants
of the Company.

 

(a) Notices
of Record Date. In the event of any taking by the Company of a record of the holders of any class of securities for the purpose
of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend which is the same as cash
dividends paid in previous quarters or a stock dividend) or other distribution, the Company shall mail to the Holder, at least
five (5) days prior to such record date, a notice specifying the date on which any such record is to be taken for the purpose
of such dividend or distribution.

 

(b) Covenants
as to Warrant Shares. The Company covenants and agrees that all Warrant Shares that may be issued upon the exercise of the
rights represented by this Warrant will, upon issuance in accordance with the terms hereof, be validly issued and outstanding,
fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance thereof. The Company further
covenants and agrees that the Company will, at all times during the Exercise Period, use its best efforts have authorized and
reserved, free from preemptive rights, a sufficient number of Warrant Shares to provide for the exercise of the rights represented
by this Warrant. If at any time during the Exercise Period the number of authorized but unissued shares of Common Stock shall
not be sufficient to permit exercise of this Warrant, the Company will take such corporate action as may, in the opinion of its
counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient
for such purposes.

 

    	 	3	 

    	 		 

    

 

(c) No
Impairment. Except and to the extent waived or consented to by the Holder, or as otherwise permitted under the terms hereof,
the Company will not, by amendment of its Certificate of Incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms to be observed or performed hereunder by the Company, but will at all times, in good faith assist in the carrying
out of all the provisions of this Warrant and in the taking of all such action as may be necessary or appropriate in order to
protect the exercise rights of the Holder against impairment.

 

6. Adjustment
of Exercise Price and Number of Warrant Shares. The number and kind of Warrant Shares purchasable upon exercise of this
Warrant and the Exercise Price shall be subject to adjustment from time to time as follows:

 

(a) Subdivisions,
Combinations and Other Issuances. If the Company shall at any time after the issuance but prior to the expiration of this
Warrant subdivide its shares of the same class and series as the Warrant Shares, by split-up or otherwise, or combine its Common
Stock, or issue additional shares of Securities as a dividend with respect to any shares of the same class or series as the Warrant
Shares, the number of Warrant Shares issuable on the exercise of this Warrant shall forthwith be proportionately increased in
the case of a subdivision or stock dividend, or proportionately decreased in the case of a combination. Appropriate adjustments
shall also be made to the Exercise Price payable per share, but the aggregate Exercise Price payable for the total number of Warrant
Shares purchasable under this Warrant (as adjusted) shall remain the same. Any adjustment under this Section 6(a) shall become
effective at the close of business on the date the subdivision or combination becomes effective, or as of the record date of such
dividend, or in the event that no record date is fixed, upon the making of such dividend.

 

(b) Reclassification,
Reorganization and Consolidation. In case of any reclassification, capital reorganization or change in the capital
stock of the Company (other than as a result of a subdivision, combination or stock dividend provided for in Section 6(a) above),
then, as a condition of such reclassification, reorganization or change, lawful provision shall be made, and duly executed documents
evidencing the same from the Company or its successor shall be delivered to the Holder, so that the Holder shall have the right
at any time prior to the expiration of this Warrant to purchase, at a total price equal to that payable upon the exercise of this
Warrant, the kind and amount of shares of stock and other securities or property receivable in connection with such reclassification,
reorganization or change by a holder of the same number and type of securities as were purchasable as Warrant Shares by the Holder
immediately prior to such reclassification, reorganization or change. In any such case appropriate provisions shall be made with
respect to the rights and interest of the Holder so that the provisions hereof shall thereafter be applicable with respect to
any shares of stock or other securities or property deliverable upon exercise hereof, and appropriate adjustments shall be made
to the Exercise Price per Warrant Share payable hereunder, provided the aggregate Exercise Price shall remain the same.

 

(c) Notice
of Adjustment. When any adjustment is required to be made in the number or kind of shares purchasable upon exercise of the
Warrant, or in the Exercise Price, the Company shall promptly notify the Holder of such event and of the number of Warrant Shares
or other securities or property thereafter purchasable upon exercise of this Warrant.

 

    	 	4	 

    	 		 

    

 

7. No
Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant, but in lieu of such fractional shares the Company shall make a cash payment therefor on the basis of the Exercise
Price then in effect.

 

8. No
Stockholder Rights. Prior to exercise of this Warrant, this Holder shall not be entitled to any rights of a stockholder
with respect to the Warrant Shares, including (without limitation) the right to vote such Warrant Shares, receive dividends or
other distributions thereon, exercise preemptive rights or be notified of stockholder meetings, and except as otherwise provided
in this Warrant, such Holder shall not be entitled to any stockholder notice or other communication concerning the business or
affairs of the Company.

 

9. Transfer
of Warrant. This Warrant is not transferable without the express written consent of the Company.

 

10. Governing
Law. This Warrant shall be governed by and construed under the laws of the Commonwealth of Massachusetts as applied to
agreements among Massachusetts residents, made and to be performed entirely within the Commonwealth of Massachusetts.

 

11. Successors
and Assigns. The terms and provisions of this Warrant and the Purchase Agreement shall inure to the benefit of, and be
binding upon, the Company and the holders hereof and their respective successors and assigns.

 

12. Titles
and Subtitles. The titles and subtitles used in this Warrant are used for convenience only and are not to be considered
in construing or interpreting this Warrant.

 

13. Notices.
All notices and other communications given or made pursuant hereto shall be in writing and shall be the provisions of
the Purchase Agreement.

 

14. Amendments
and Waivers; Resolutions of Dispute; Notice. The amendment or waiver of any term of this Warrant, the resolution of any
controversy or claim arising out of or relating to this Warrant and the provision of notice shall be governed by the applicable
provisions of the Purchase Agreement.

 

15. Severability.
If any provision of this Warrant is held to be unenforceable under applicable law, such provision shall be excluded from
this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and shall be enforceable
in accordance with its terms.

 

IN
WITNESS WHEREOF, the parties have executed this Warrant as of the date first above written.

 

	 	OXYGEN
    THERAPY INC.
	 	 
	 	By:	 
	 	Name:	Yuval
    Kwinter
	 	Title:	President

 

    	 	5	 

    	 		 

    

 

NOTICE
OF EXERCISE

 

TO:
OXYGEN THERAPY INC.

 

(1) [  ]The
undersigned hereby elects to purchase ________Warrant Shares (the “Exercise Shares”) of Oxygen Therapy Inc.
(the “Company”) pursuant to the terms of the attached Warrant, and tenders herewith payment of the Exercise
Price in full, together with all applicable transfer taxes, if any.

 

[  ]The
undersigned hereby elects to purchase____________________Warrant Shares (the “Exercise Shares”) of Oxygen
Therapy Inc. (the “Company”) pursuant to the terms of the Net Exercise provisions set forth in Section
4 of the attached Warrant, and shall tender payment of all applicable transfer taxes, if any.

 

(2) Please
issue a certificate or certificates representing said Exercise Shares in the name of the undersigned or in such other name as
is specified below:

 

(Name)

 

(Address)

 

(3) The
undersigned represents that (i) the aforesaid Exercise Shares are being acquired for the account of the undersigned for investment
and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention
of distributing or reselling such shares; (ii) the undersigned is aware of the Company’s business affairs and financial
condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision regarding
its investment in the Company; (iii) the undersigned is experienced in making investments of this type and has such knowledge
and background in financial and business matters that the undersigned is capable of evaluating the merits and risks of this investment
and protecting the undersigned’s own interests; (iv) the undersigned understands that Exercise Shares issuable upon exercise
of this Warrant have not been registered under the Securities Act of 1933, as amended (the “Securities Act”),
by reason of a specific exemption from the registration provisions of the Securities Act, which exemption depends upon, among
other things, the bona fide nature of the investment intent as expressed herein, and, because such securities have not been registered
under the Securities Act, they must be held indefinitely unless subsequently registered under the Securities Act or an exemption
from such registration is available; (v) the undersigned is aware that the aforesaid Exercise Shares may not be sold pursuant
to Rule 144 adopted under the Securities Act unless certain conditions are met and until the undersigned has held the shares for
the number of years prescribed by Rule 144, that among the conditions for use of the Rule is the availability of current information
to the public about the Company and the Company has not made such information available and has no present plans to do so; and
(vi) the undersigned agrees not to make any disposition of all or any part of the aforesaid shares of Exercise Shares unless and
until there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition
is made in accordance with said registration statement, or, if reasonably requested by the Company, the undersigned has provided
the Company with an opinion of counsel satisfactory to the Company, stating that such registration is not required. Notwithstanding
the above, no such registration statement or opinion of counsel shall be necessary for a transfer without receipt of consideration
by the undersigned to (i) a partner (or retired partner) or member (or retired member) of the undersigned in accordance with partnership
or limited liability company interests or (ii) a corporation transferring to a wholly owned subsidiary or a parent corporation
that owns all of the capital stock of the undersigned or a corporation to its shareholders in accordance with their interest in
the corporation, or transfers by gift, will or intestate succession to any spouse or lineal descendants or ancestors, if all transferees
agree in writing to be subject to the terms hereof.

  

	 	 	 
	(Date)	 	(Signature)
	 	 	 
	 	 	(Print
    Name)EXHIBIT
10.3

 

Form
of Employment Agreement

 

OXYGEN
THERAPY, INC.

 

[Date]

 

[name
of employee and address]

 

Dear_____________,

 

Oxygen
Therapy, Inc. (together with any affiliates, the “Company”) is pleased to confirm its offer to employ as __________
and [office] reporting to the Board of Directors. As discussed, your official start date with the Company was effective ________,
2016, the date of the Company’s organization. 

 

This
position will be unpaid until a later date determined by the Board of Directors. You also will be entitled to three weeks of paid
vacation that begins accruing on a monthly basis from your first day of employment.

 

Upon
the fulfillment of any eligibility requirements, you will be eligible to participate in the employee benefit plans that the Company
may offer to its employees. Descriptions of the benefit plans currently being offered, if any, have been delivered to you. Any
Company benefit plan may, from time to time, be amended or terminated by Company in its sole discretion with or without prior
notice.

 

This
employment offer is contingent upon the conditions outlined below. Please understand the resulting formality of this offer letter.

 

	 	1)	As
    a condition of employment (or continuing employment) with the Company, you are required to execute the enclosed CONFIDENTIALITY
    AND DEVELOPMENTS AGREEMENT (“Agreement”). This is an important legal document that restricts certain activities
    during your employment and for a period of time after you leave the Company. You should carefully read the entire document,
    review its provisions with your counsel and advisors, and decide whether or not to enter into this Agreement. You must sign
    and return the Agreement to me no later than one week prior to your start date.
	 	 	 
	 	2)	Your
    employment (or continued employment) by the Company is based in part on your acceptance and agreement not to compete with
    the Company. Specifically, you agree that for a period of twelve (12) months from the date of termination of your employment
    or cessation of your business relationship with the Company you will not, either alone or in conjunction with any person or
    entity, directly, or indirectly (a) cause or attempt to cause any client, customer, distributor, partner, joint venturer or
    supplier of the Company or any of the Company’s affiliates to terminate or materially reduce its business with the Company
    or any such affiliate or (b) participate, accept employment or engage in (other than through the ownership of two percent
    (2%) or less of any class of securities registered under the Securities Act), or otherwise lend assistance (financial or otherwise)
    to any person or entity participating or engaged in any line of business in which the Company is participating or engaged
    on the date hereof anywhere in the world.

 

    	 		 

    	 		 

    

 

	 	3)	In
    making this offer of employment (or in agreeing to continue your employment), the Company is relying upon your representation
    that you are not under any obligation to any former employer or any person, firm, or corporation that would prevent, limit,
    or impair in any way the performance by you of your duties as an employee of the Company.
	 	 	 
	 	4)	The
    Immigration Reform and Control Act requires employers to verify the employment eligibility and identity of new employees.
    Enclosed is a copy of the Form 1-9 that you will be required to complete. Please bring this form and appropriate documents
    listed on the form with you on the first day you report for work.
	 	 	 
	 	5)	You
    may be required to undergo a background check, including a criminal background check, at any time during your employment,
    and your employment is contingent upon results satisfactory to the Company.
	 	 	 
	 	6)	Your
    employment with the Company is an at-will employment relationship. This means that your employment is not guaranteed for any
    specified period of time and you or the Company may terminate the relationship at any time, with or without notice or cause.
    The Company simply asks that you provide reasonable notice of your departure.
	 	 	 
	 	7)	You
    are the record and beneficial owner of a significant number of shares of the Common Stock of the Company and you have acknowledged
    and agreed that (a) the Company intends to file a registration statement on Form S-1 or other appropriate form with the SEC
    in order to register shares of the Company’s common stock for sale and distribution, and (b) you agree that you will
    not directly or indirectly, nor direct any person acting on behalf of or pursuant to any understanding with you, execute any
    purchases or sales, including, without limitation, short sales, of any securities of the Company during the period commencing
    on the date the Company files a registration statement with the SEC and ending 180 days after the effective date of such registration
    statement.
	 	 	 
	 	8)	If
    your employment relationship with the Company is terminated without cause prior to August 31, 2020, then the Company shall
    pay you a lump sum of $100,000 in severance, such payment to be conditioned upon your execution and delivery of a general
    release and covenant not to sue the Company containing standard or “market” terms; provided, however, that from
    and after the date by which the Company has raised on a cumulative basis a gross amount equal to or in excess of $5,000,000,
    the severance payment shall be increased from $100,000 to $300,000. 

 

If
there is anything about the offer of employment that was verbally made to you but is not mentioned in this letter, please contact
me as soon as possible to discuss it. Otherwise, it will be understood that this letter fully encompasses all aspects of our offer
of employment to you and supersedes all prior offers, both verbal and written.

 

    	 	2	 

    	 		 

    

 

Please
indicate your acceptance of this Agreement by signing and dating the enclosed copies of this letter and the Agreement, and returning
them in the enclosed envelope.

 

We
are pleased that you will be working with us. Please do not hesitate to call me if you have any questions.

 

	Sincerely,	 	 	 
	 	 	 	 
	OXYGEN
    THERAPY, INC.	 	 	 
	 	 	 	 	 
	By:	 	 	 	 
	 	 	 	 	 
	Agreed
    & Accepted:	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	[Name]	 	Date	 

 

    	 	3	 

    	 		 

    

 

OXYGEN
THERAPY, INC.

 

CONFIDENTIALITY
AND DEVELOPMENTS AGREEMENT

 

Effective
_____, 2016 (the “Effective Date”), and in consideration and as a condition of my employment by or service to Oxygen
Therapy, Inc., a Delaware corporation (the “Company”), I hereby agree as follows:

 

1.
Confidentiality.

 

(a)
I shall not at any time, whether during or after
the termination of my employment, disclose to any person or entity or otherwise use any Confidential Information (as defined herein)
except as may be required in the ordinary course of performing my duties as an employee of the Company. For purposes of this Agreement,
“employment” means my current or subsequent retention as a full- or part-time employee, contractor, or consultant
to the Company, or engagement by the Company in any other capacity, whether or not I receive compensation from the Company. I
shall keep confidential all matters entrusted to me and shall not use any Confidential Information in any manner that may injure
or cause loss or may be calculated to injure or cause loss to the Company, whether directly or indirectly.

 

(b)
The term “Confidential Information”
shall include any information concerning Developments (as defined herein) and all other business, technical and financial information
of the Company or of any third party, including, without limitation, products, customer lists, customer information, employee
information, pricing information, business plans, projects, plans and proposals, that is disclosed to or learned by me during
the course of my employment by or service to the Company. The term “Confidential Information” shall not include any
information that is or becomes readily publicly available without restriction through no fault of mine.

 

(c)
I acknowledge and agree that all Company Property
is and shall remain the sole and exclusive property of the Company. Immediately upon the termination of my employment, or sooner
upon the request of the Company, I shall deliver the originals and all copies of Company Property in my possession, custody or
control to the Company. I further agree that I shall not, during the period of my employment and after the termination of my employment,
use or permit unauthorized employees or non-employees to use any Company Property. The term “Company Property” shall
include: (i) all materials containing or embodying Confidential Information; (ii) all notes, memoranda, reports, lists, records,
drawings, sketches, specifications, software programs, software code, data, documentation or other materials of any nature and
in any form, whether written, printed, electronic or in digital format or otherwise relating to any matter within the scope of
the business of the Company or concerning any of its dealings or affairs; (iii) all computers, cellular telephones, credit and/or
calling cards, keys, and access cards issued to me, or otherwise paid for, by the Company; and (iv) any other property of the
Company in my possession, custody or control.

 

    	 		 

    	 		 

    

 

2.
Assignment of Developments.

 

(a)
If: (i) at any time or times during my employment,
I shall (either alone or with others) make, conceive, create, discover, invent or reduce to practice (in whole or in part) any
Development (as defined herein) that (A) relates to the actual, conceived, anticipated or proposed business, research or development
of the Company or any customer of or supplier to the Company or any of the products or services being developed, manufactured
or sold by the Company or which may be used in relation therewith; or (B) results from tasks assigned to me by the Company; or
(C) results from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by
the Company (including any Confidential Information) ; or (ii) at any time or times prior to my employment I (either alone or
with others) made, conceived, created, discovered, invented, or reduced to practice (in whole or in part) any such Development,
then all right, title and interest relating to all such Developments (including Developments under subsection (i) and (ii) of
this Section 2(a)) are and shall immediately become the sole and absolute property of the Company and its assigns, as works made
for hire or otherwise. I hereby assign and agree to assign all right, title and interest (including, but not limited to, rights
to inventions, patentable subject matter, mask work rights, copyrights, trade secrets and trademarks) in such Developments (including
all intellectual property rights embodied therein) and all benefits and/or rights resulting therefrom to the Company and its assigns
without further compensation and shall communicate, without cost or delay, and without disclosing to others the same, all available
information relating thereto (with all necessary plans and models) to the Company. I shall promptly disclose to the Company (or
any persons designated by it) each such Development. If I use or disclose my own or any third party’s confidential information
or intellectual property when acting within the scope of my employment or otherwise on behalf of the Company, or if any Development
assigned hereunder cannot be fully made, conceived or reduced to practice without violating or infringing any intellectual property
rights, the Company will have and I hereby grant the Company a perpetual, irrevocable, worldwide royalty-free, non-exclusive,
sublicensable, transferable right and license to freely exploit all such confidential information, intellectual property and/or
intellectual property rights. I will not use or disclose any of my own or any third party’s confidential information or
intellectual property for which I do not have the right to grant the foregoing license.

 

(b)
The term “Development” shall mean
any concept, invention, discovery, design, development, improvement, process, method, system, algorithm, software program, work
of authorship, mask work, documentation, formula, data, technique, know-how, trade secret, idea, information or intellectual property
right whatsoever or any interest therein, whether or not it may be patented, registered or otherwise protected, including all
versions, modifications, enhancements and derivative works thereof. To the extent permitted under applicable law, Developments
include all rights to paternity, integrity, disclosure and withdrawal and any other rights that may be known or referred to as
moral rights, artist’s rights or the like (“Moral Rights”); and to the extent I retain any Moral Rights under
applicable laws I hereby ratify and consent to any action that may be taken with respect to such Moral Rights by or authorized
by the Company and agree not to assert any Moral Rights with respect thereto. I will confirm any such ratification, consent or
agreement from time to time as requested by the Company.

 

(c)
I shall, during my employment and at any time
thereafter, at the request and cost of the Company, further assist the Company to further evidence, record and perfect the licenses
and assignments set forth herein, and to perfect, obtain, renew, restore, maintain, enforce, and defend any rights specified to
be so licensed, owned or assigned. I hereby irrevocably designate and appoint the Company as my agent and attorney-in-fact to
act for and in my behalf to execute and file any document and to do all other lawfully permitted acts to further the purposes
of the foregoing with the same legal force and effect as if executed by me.

 

    	 	2	 

    	 		 

    

 

(d)
If I wish to clarify that something created by
me prior to my employment that relates to the Company’s actual or proposed business is not within the scope of this Agreement,
I have listed it on Schedule A attached hereto.

 

3.
Non-Solicitation, Etc. I shall not, during
the period of my employment with the Company and for one year thereafter, directly or indirectly solicit, request, encourage,
assist or cause (a) any person who is employed by or a consultant to the Company or any affiliate or subsidiary of the Company
either during my period of employment or during such one year period, to terminate such person’s employment by or consultancy
to the Company, such affiliate or subsidiary, or (b) any past, present or prospective customer, supplier, vendor or other business
partner of the Company or any affiliate or subsidiary of the Company to do business with me or any entity in which I have an interest
as an equity owner, officer, director, partner, agent, affiliate, or in any other capacity. As used herein the term “solicit”
shall include, without limitation, requesting, encouraging, assisting or causing, directly or indirectly, any employee or consultant
to terminate such person’s employment by or consultancy to the Company, affiliate or subsidiary.

 

4.
Employment At Will. I understand that
nothing herein shall be construed as constituting an employment agreement or an undertaking by the Company to retain my services
for any stated period of time. Accordingly, I understand that my employment with the Company is “at will” and that
the Company has the right to terminate my employment at any time, for any reason or no reason, with or without cause. This Agreement
does not purport to set forth all of the terms and conditions of my employment, and as an employee of the Company, I have obligations
to the Company which are not described in this Agreement. However, the terms of this Agreement govern over any such terms that
are inconsistent with this Agreement, and supersede the terms of any similar form that I may have previously signed.

 

5.
Conflicts. During the period of my employment
with the Company, I shall neither engage in any business opportunity outside the Company nor be employed in any organization other
than the Company without the approval of a majority of the Company’s Board of Managers.

 

6.
Continuing Obligations. My obligations
under this Agreement shall survive and shall not be affected by: (i) any termination of my employment, including termination upon
the Company’s initiative; (ii) any change in my position, title or function with the Company; or (iii) any interruption
in my employment during which I leave and then rejoin the Company within a period of six (6) months. I understand that the Company
shall be entitled to communicate my obligations under this Agreement to any future employer or potential employer of mine.

 

7.
No Conflicting Agreements. I have not
made and agree not to make any agreement, oral or written, that is in conflict with this Agreement or my employment with the Company.
I have no present obligations to assign to any former employer, or to any other person not affiliated with the Company, any Developments
covered by Section 2 hereof. I will not, and will not cause the Company to, violate any agreement with or rights of any third
party or, except as expressly authorized by the Company in writing hereafter, use or disclose my own or any third party’s
confidential information or intellectual property in the course of my employment with the Company.

 

    	 	3	 

    	 		 

    

 

8.
Remedies. I agree that in the event of
any breach by me of any of the provisions of this Agreement, the Company shall be entitled, in addition to monetary damages and
to any other remedies available to the Company under this Agreement and at law, to equitable relief, including injunctive relief,
and to payment by me of all costs incurred by the Company in enforcement against me of the provisions of this Agreement, including
reasonable attorneys’ fees, provided that the Company is successful on the merits of such claim.

 

9.
Severability. If any provision of this
Agreement shall be found to be invalid, inoperative or unenforceable in law or equity, such finding shall not affect the validity
of any other provisions of this Agreement, which shall be construed, reformed and enforced to effect the purposes of this Agreement
to the fullest extent permitted by law. If one or more of the provisions contained herein shall for any reason be held to be excessively
broad in scope, activity, subject or otherwise so as to be unenforceable at law, such provision(s) shall be construed by the appropriate
judicial body by limiting or reducing it (or them) so as to be enforceable to the maximum extent under the applicable law.

 

10.
No Waiver. Waiver of any provision of
this Agreement, in whole or in part, in any one instance shall not constitute a waiver of any other provision in the same instance,
nor any waiver of the same provision in another instance, but each provision shall continue in full force and effect with respect
to any other then-existing or subsequent breach. No delay or omission to exercise any right, power or remedy under this Agreement
by the Company upon a breach or default by me shall impair any such right, power or remedy of the Company, nor shall it be construed
to be a waiver of any such breach or default

 

11.
Consent to Jurisdiction. I agree that
any suit, action or proceeding instituted against me or the Company under or in connection with this Agreement shall be brought
only in a court of competent jurisdiction of the Commonwealth of Massachusetts or in the U.S. District Court for the District
of Massachusetts. By execution hereof, I irrevocably waive any objection to, and any right of immunity on the grounds of, improper
venue, the convenience of the chosen forum, the personal jurisdiction of such courts or the execution of judgments resulting therefrom.
I irrevocably accept and submit to the exclusive jurisdiction of such courts in any such action, suit or proceeding. I agree that
the delivery of any writ, judgment or other notice of legal process in connection with any suit, action or proceeding in any of
such courts, to me anywhere in the world shall constitute sufficient service thereof on me.

 

12.
Miscellaneous. I understand that this
Agreement: (i) may be executed in any number of counterparts, each of which, when executed by both parties to the Agreement shall
be deemed to be an original, and all of which counterparts together shall constitute one and the same instrument; (ii) shall be
governed by and construed under the law of the Commonwealth of Massachusetts, without application of principles of conflicts of
laws; (iii) shall constitute the entire agreement between the Company and me with respect to the subject matter hereof, superseding
all prior oral and written communications, proposals, negotiations, representations, understandings, courses of dealing, agreements,
contracts, and the like between the Company and me in such respect; (iv) may be amended, modified, or terminated, and any right
under this Agreement may be waived in whole or in part, only by a writing signed by both the Company and me; (v) contains headings
only for convenience, which headings do not form part, and shall not be used in construction, of this Agreement; (vi) shall be
binding upon my heirs, executors, administrators and legal representatives; (viii) may be assigned by the Company to its successors
and assigns, and all covenants and agreements hereunder shall inure to the benefit of and be enforceable by said successors or
assigns.

 

    	 	4	 

    	 		 

    

 

IN
WITNESS WHEREOF, the undersigned has executed this Agreement as a sealed instrument effective as of the Effective Date.

 

	 	 	 
	 	 	Signature
	 	 	 
	 	 	 
	 	 	Name
    (Please Print)

 

	 	 	Address:	 
	 	 	 	 
	 	 	 	 

 

	AGREED
    AND ACCEPTED TO:	 	 
	 	 	 
	OXYGEN
    THERAPY, INC.	 	 
	 	 	 	 
	By:	 	 	 
	 	 	 	 
	Name:	 	 	 
	 	 	 	 
	Title:	 	 	 

 

    	 	5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00263-of-00352.parquet"}]]